BIONIK
  • Solutions
    • InMotion® Therapy
    • InMotion® ARM
    • InMotion® ARM/HAND
    • InMotion® EVAL
    • InMotion® Connect
    • InMotion® for PT
    • InMotion® for OT
  • Evidence
    • Featured Webinars
    • Testimonials
    • Published Research
    • Clinical Guidelines
  • Blog
  • News
    • Media Coverage
    • Press Releases
  • Events
    • Conferences
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Investors
    • Careers
    • Contact
Select Page

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo

Mar 30, 2022

BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report

Mar 29, 2022

BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results

Feb 9, 2022

BIONIK Laboratories to Participate at the American Physical Therapy Association Conference

Jan 31, 2022

BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry

Nov 11, 2021

BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results

Nov 10, 2021

BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto

Oct 28, 2021

BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform

Sep 22, 2021

BIONIK Laboratories Reports Fiscal 2022 Q1 Financial Results

Aug 12, 2021

BIONIK Laboratories Announces $5 Million Capital Raise through Issuance of Convertible Notes

Jul 29, 2021
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12

    Clinical Evidence

    • About
    • Investors
    • Disclaimer
    • Privacy Policy

    News + Events

    • Recent News
    • Events
    • Press Releases

    Support

    • Contact Us
    • Cleaning Procedures
    Global Headquarters

    80 Coolidge Hill Road
    Watertown, MA 02472
    United States
    Tel: +1 617.926.4800
    support@bioniklabs.com
    ©2022 BIONIK